---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-009327"
form_type: "8-K"
ticker: "DWTX"
cik: "0001818844"
company_name: "Dogwood Therapeutics, Inc."
filed_at: "2024-06-20T23:59:59+00:00"
generated_at: "2026-06-01T03:38:37.801437+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Virios Therapeutics annual meeting elects all six director nominees, ratifies FORVIS as auditor

## Summary
- Quorum of 8,699,494 shares (45.17% of voting power) present at June 18, 2024 meeting.
- All six director nominees elected: Burch (3,201,273 for), De La Rosa (2,440,247), Duncan (3,183,237), Keefer (3,198,840), Thomas (3,201,528), Whitley (1,964,627).
- Highest withheld votes were for Dr. Whitley with 1,442,138 withheld.
- Ratification of FORVIS LLP as auditor for FY2024 approved with 8,347,686 for, 241,056 against, 110,752 abstain.
- No broker non-votes on auditor ratification; broker non-votes of 5,292,729 on director elections.

## SEC filing metadata
- accession: 0001558370-24-009327
- form_type: 8-K
- ticker: DWTX
- cik: 0001818844
- company_name: Dogwood Therapeutics, Inc.
- filed_at: 2024-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818844/000155837024009327/0001558370-24-009327-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818844/000155837024009327/viri-20240618x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-009327
- JSON: https://secwatch.observer/filing/0001558370-24-009327.json
- Plain text: https://secwatch.observer/filing/0001558370-24-009327.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.